Janux Therapeutics · 21 hours ago
Vice President/Senior Vice President, Clinical Development (AID)
Janux Therapeutics is focused on developing innovative therapies for autoimmune diseases, and they are seeking a strategic leader for their clinical development programs. The Vice President/Senior Vice President will drive the vision and execution of clinical strategies while ensuring clinical integrity and overseeing medical monitoring.
BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Responsibilities
Set and execute the strategic vision for clinical development in autoimmune diseases, ensuring alignment with corporate goals and maximizing portfolio value
Lead cross-functional teams in the design and implementation of clinical development strategies, focusing on innovation, differentiation, and speed to market
Oversee clinical program execution at a strategic level, delegating operational and hands-on responsibilities to clinical teams and direct reports
Maintain ultimate accountability for medical monitoring, ensuring patient safety and clinical integrity, but delegate day-to-day monitoring activities to appropriate team members
Provide expert guidance and strategic input on clinical trial design, regulatory strategy, and data interpretation
Serve as the primary medical and scientific spokesperson for the immunology franchise, internally and externally
Cultivate relationships with key opinion leaders, investigators, and external partners to advance Janux’s immunology pipeline
Drive organizational growth, talent development, and succession planning within the clinical development function
Other duties as deemed essential
Qualification
Required
MD or DO with subspecialty in immunology, autoimmune diseases, or related fields
Demonstrated success as a senior clinical leader (e.g., therapeutic area head, franchise lead) in large pharma or biotech, with broad immunology experience
Proven track record of strategic leadership in clinical development, portfolio management, and cross-functional team building
Innovative, entrepreneurial mindset; experience driving change and building new capabilities
Deep understanding of early drug development, clinical trial processes, and regulatory requirements in immunology/inflammation
Exceptional communication, influence, and stakeholder management skills
Strong ability to critically evaluate data, literature, and presentations
High level of communication skills is expected
Benefits
401K
Medical insurance
Dental insurance
Vision insurance
Supplemental disability insurance plans
Flexible schedule
Life insurance
Flexible vacation
Sick time
Incentive stock option plan
Relocation assistance
Company
Janux Therapeutics
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Funding
Current Stage
Public CompanyTotal Funding
$898.94MKey Investors
RA Capital ManagementAvalon Ventures
2024-12-03Post Ipo Equity· $350M
2024-02-29Post Ipo Equity· $296.5M
2023-07-17Post Ipo Equity· $60M
Leadership Team
Recent News
2025-12-24
2025-12-04
2025-12-03
Company data provided by crunchbase